| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. | Director | Common Stock, par value $0.0001 per share | 2.82K | $84.5K | $30.00 | May 30, 2024 | Direct |
| Corbus Pharmaceuticals Holdings, Inc. | Director | Stock Option (right to buy) | 2.78K | $13.8K | $4.97 | May 16, 2024 | Direct |
| Provention Bio, Inc. | Director | Option to Purchase Common Stock | 0 | Apr 27, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | May 30, 2024 | 1 | $0 | 4 | Jun 3, 2024 | Director |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | May 16, 2024 | 1 | $0 | 4 | May 20, 2024 | Director |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | May 18, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
| PRVB | Provention Bio, Inc. | Apr 27, 2023 | 3 | $0 | 4 | Apr 27, 2023 | Director |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | May 18, 2022 | 1 | $0 | 4 | May 19, 2022 | Director |
| PRVB | Provention Bio, Inc. | May 17, 2022 | 1 | $0 | 4 | May 18, 2022 | Director |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | Jun 17, 2021 | 2 | $0 | 4 | Jun 17, 2021 | Director |
| PRVB | Provention Bio, Inc. | May 12, 2021 | 1 | $0 | 4 | May 14, 2021 | Director |